Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Yantai Dongcheng Pharmaceuticl Gp (002675 CH)
Watchlist
12
Analysis
Health Care
•
China
Yantai Dongcheng Pharmaceutical Co Ltd is an enterprise group that combines pharmaceutical R&D, production, marketing, and capital operations across the fields of biochemical API, chemical synthetic drugs, and modern Chinese medicine.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Shenzhen HepaLink Pharmaceutical (H)
•
07 Jul 2020 16:08
Hepalink Pharma IPO: Trading Debut
Shenzhen HepaLink Pharmaceuticals (H) (HEPALINK HK) is a leading China-based pharmaceutical company with global businesses in pharmaceutical,...
Arun George
Follow
396 Views
Share
bullish
•
Shenzhen HepaLink Pharmaceutical (H)
•
23 Jun 2020 19:20
Hepalink Pharma IPO: Valuation Insights
Shenzhen HepaLink Pharmaceuticals (H) (HEPALINK HK) is a leading China-based pharmaceutical company with global businesses in pharmaceutical,...
Arun George
Follow
469 Views
Share
bearish
•
Thematic (Sector/Industry)
•
06 Oct 2016 21:27
Falling Fertility Adds to China's Population Woes
By allowing couples to have up to two children China hopes to reverse its likely population decline. But falling fertility and the pressures of...
Bixmoor
Follow
4.1k Views
Share
bearish
•
Thematic (Sector/Industry)
•
12 Sep 2016 23:18
Iran Shows China the Way on Population Expansion
Faced with dramatically falling birth rates, Iran has introduced a wide range of pro-natalist policies. In contrast, China has been half-hearted in...
Bixmoor
Follow
188 Views
Share
bearish
•
Thematic (Sector/Industry)
•
18 Aug 2016 18:43
Small Improvement in China Air Quality
Air quality in China appears to have improved slightly in recent months. However, it is still well above World Health Organisation recommended...
Bixmoor
Follow
220 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.30.3
x